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Kardiovaskulære endringer under dykking: Fra menneskelig respons til cellulær 
funksjon.  
 
Menneskekroppen er evolusjonsmessig tilpasset et liv på land, men etter at dykking med 
komprimert luft ble allment tilgjengelig så har mennesket kunnet utforske verdenshavene på 
en helt ny måte. Imidlertid må kroppen raskt tilpasse seg et økende trykk under nedstigning 
og for at lungene ikke skal kollapse må luft alltid tilføres under høyt trykk. Avhengig av 
dybde og tid vil kroppen ta opp en viss mengde gass og ved retur til overflaten kan 
overmetning av gass føre til dannelse av gassbobler og mulig trykkfallsyke. Samtidig vil det 
kardiovaskulære systemet bli utsatt for betydelige påkjenninger under de ulike fasene av et 
dykk, og hovedmålet med dette arbeidet har vært å evaluere om kunnskap fra dyrestudier kan 
bidra til økt forståelse av de fysiologiske endringer man finner hos mennesket og dermed 
minimalisere risikoen for skader forbundet med dykking.  
 
Denne avhandlingen er basert på tre studier hvor den første studien evaluerte hvilke effekter 
dyp luftdykking hadde på lunge og hjertefunksjon og varigheten av disse symptomene. Ved 
bruk av ultralyd ble det stadfestet at symptomer på interstitiell lunge ødem (ultralyd 
lungekometer (ULC)) forsvant etter 2-3 timer etter påfølgende dykk, og symptomer på nedsatt 
hjertefunksjon ble dokumentert etter hvert dykk. I dag blir slike målinger på menneske kun 
utført i forkant av- og etter dykking da det ikke finnes utstyr for å gjøre målinger under selve 
dykket. For å få økt forståelse av hvordan det kardiovaskulære systemet blir påvirket av 
dykking ved ulike tidspunkt og dermed en bedre forståelse av de endingene som er observert 
hos mennesket etter dykk, ble det andre studiet initiert. Her ble kardiovaskulære endringer hos 
anesteserte rotter kontinuerlig evaluert med et trykk volum kateter (PV-loop) i venstre 
ventrikkel og femoral arterien. Rottene ble utsatt for et simulert dykk i trykk-kammer og 
resultatene viste at de mest framtredende endringer fant sted under kompresjonsfasen og 
gradvis returnerte til utgangsverdier under dekompresjon og etter dykk. I tillegg undersøkte vi 
om en moderat nedkjøling under dekompresjonsfasen og oppvarming igjen etter dykk ville 
endre utfallet av dykket. Vi fant ingen økt risiko for trykkfallsyke, men observerte en 
overrakende nedgang i slagvolum og minuttvolum etter re-varming. I den tredje studien 
undersøkte vi om immersjon (nedsenking i vann) i kombinasjon med et simulert dykk kunne 
gi cellulære endringer i hjertet og dermed økt risiko for trykkfallsyke sammenliknet med 
hyperbart dykk uten immersjon (tørt dykk). Effekten av immersjon på det kardiovaskulære 
system ble funnet å vedvare over tid. De dyr som hadde oppholt seg i vann før det simulerte 
dykket fikk nedsatt hjertecelletfunksjon samt økt boblegrad sammenliknet med de dyr som 
ikke hadde vært nedsenket i vann. Hvorfor dykk i vann resulterer i økt risiko for trykkfallsyke 
enn dykk i tørre omgivelser er uklart, men det viser at man ikke bør direkte overføre 
prosedyrer fra tørre dykk til dykk i vann. 
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Abbreviations  
 
APE  Acute pulmonary edema 
ATA  Atmosphere absolute 
Ca2+  Calcium 
[Ca]2+  Intracellular calcium concentration 
CO  Cardiac output 
DCS  Decompression sickness 
DLCO  Diffusion lung capacity of carbon monoxide 
He  Helium gas 
HR  Heart rate 
kPa  Kilopascal 
LV  Left ventricle 
LV dP/dtmax Maximal velocity of LVP rise  
LV-EDV Left ventricular end-diastolic volume 
LV-EDP Left ventricular end-diastolic pressure  
LV-ESP Left ventricular end-systolic pressure 
LV-ESV Left ventricular end-systolic volume 
LVP  Left ventricular pressure 
MAP  Mean arterial pressure 
MSW  Meter of seawater 
N2  Nitrogen gas 
NCX  Na+/Ca2+ exchanger 
NT-proBNP N-terminal prohormone brain natriuretic peptide 
O2  Oxygen gas 
PA  Pulmonary artery 
PLN  Phospholamban 
PLN 16P Serine-16 site of Phospholamban 
PLN 17P Threonine-17 site of Phospholamban 
PO2  Partial pressure of oxygen 
proANP Pro-atrial natriuretic peptide  
RV   Right ventricle 
SCUBA Self contained underwater breathing apparatus 
SERCA2a Sarcoplasmatic reticulum calcium ATPase, isoform 2a 
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SR  Sarcoplasmatic reticulum 
SV  Stroke volume 
SVR  Systemic vascular resistance 
TRP  Total peripheral resistance 
TTP50  Time to peak 50% shortening 
ULC  Ultrasonic lung comets 
VGB  Venous gas bubble 
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Definitions 
 
Afterload: The load the ventricle has to overcome during contraction. 
 
Calcium handling: The ability of the cardiomyocyte to regulate intracellular calcium levels 
during contraction and relaxation. 
 
Cardiomyocyte shortening: The shortening of a cardiomyocyte from end-diastole to end-
systole, divided by end-diastolic length. 
 
Immersion: The organism is submersed in water. 
 
Inert gas: Biochemically inactive gas that is not involved in metabolic processes. In diving 
inert gas is usually N2/H2 and is the main contributor to decompression bubbles. 
 
Mean arterial pressure: Diastolic pressure + 1/3 of pulse pressure. 
 
Nitrox: Gas mixture (N2/O2) with oxygen levels higher than air.  
 
Preload: The load present before ventricular contraction has started, at the end of diastole. It 
reflects the venous filling pressure that fills the left atrium, which in turn fills the left ventricle 
during diastole.  
 
Pulse pressure: Systolic pressure – diastolic pressure. 
 
Total peripheral resistance: Mean arterial pressure/Cardiac output. 
 
Trimix: Gas mixture (He/N2/O2) used for diving. 
 
Ultrasonic lung comet (ULC) detection: Ultrasonic lung imaging to estimate the severity of 
extravascular lung water by counting the number of ULCs. 
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Background 
Although not adapted to the underwater environment, man has always had the urge to explore 
the possibilities and mysteries of the deep. Compared to other mammals that are able to 
perform breath-hold dives up to 1500 meter of seawater (msw) [1], humans have considerable 
limitations. Due to the invention of self contained breathing apparatus (SCUBA), new 
possibilities emerged and today diving is a popular world wide activity both at the 
recreational and professional level. However, diving demands rapid physiological adaptations 
and in order to prevent the lungs from collapsing at increased ambient pressure, air must be 
supplied under high pressure. The amount of gas taken up in a diver’s body increases with 
depth and time, and unlike oxygen (O2) and carbon-dioxide (CO2) which are metabolized, 
inert gases are biologically inactive and are absorbed in tissues. Various depths require 
different breathing gas compositions and at greater depths the inert nitrogen (N2) gas is often 
substituted with the inert helium gas (He) due to its advantages over nitrogen [2]. 
Nevertheless, diving can be harmful and the major risk relates to formation of gas bubbles 
upon return to the surface [3]. Along with environmental factors such as immersion and 
temperature, these bubbles can induce long term depressive alteration of the cardiovascular 
system in humans, lasting up to several days [4]. The mechanisms behind these observations 
are unclear and in addition it is still an enigma why there is a large individual variation in 
susceptibility for bubble formation. To gain a more comprehensive understanding of the 
clinical signs observed after diving, translational research is needed. Combining cellular and 
molecular data from animal studies with human data is crucial for improved safety and 
treatment strategies after a dive.   
 
Vascular gas bubbles and pathophysiological effects 
Vascular gas bubbles are observed after nearly all decompressions [5] and these bubbles are 
considered to be the initiators of the pathophysiological cascade leading to decompression 
sickness (DCS). Haldane proposed that DCS would be avoided if bubbles were not present 
and that bubbles would not occur after decompression if supersaturation did not exceed a 
critical value [6]. Supersaturation occurs when ambient pressure is reduced at a faster rate 
than gas can be elimination from the tissues. The mechanisms for bubble production are still 
not completely understood but today it is generally held that bubbles do not directly form de 
novo from supersaturation but from pre-existing gas nuclei [7]. Although no direct 
 8
observations exist, it has been hypothesized that these nuclei attach and grow on the 
endothelial lining of the vessel wall [3] and that the number and size is affected by the surface 
tension in the blood [3]. 
 
Intravascular gas bubbles are more likely to form on the venous side of the circulation due to 
lower gas tension and blood pressure on the arterial side [8]. In most cases these bubbles do 
not lead to any clinical signs of DCS and are thus named “silent bubbles” [9]. However, DCS 
risk appears to be higher in the presence of bubbles [10] and assessment of bubbles by 
ultrasound imaging is widely used to quantify decompression stress. The lung has a good 
filter capability for gas bubbles but bubbles may gain access to the arterial circulation due to 
gas overload in the lung [11] or patent foramen ovale (PFO). PFO is present in approximately 
30% of adult humans and its occurrence is shown to be related to neurological DCS [12].  
 
The innermost layer of the vessel wall, the endothelium, is a crucial modulator of the vascular 
tone. Various physiological stimuli triggers its release of multiple vasoactive substances, 
including nitric oxide (NO), which influences upon e.g blood flow, blood coagulation and 
angiogenesis [13]. This fragile layer seems to play an important role for gas bubble 
production but it can also be damaged or get reduced function in response to gas bubbles in a 
dose dependent manner [14, 15]. This will active inflammatory responses such as leucocytes 
and platelets [16, 17], cogulation system [18] and the complement cascade [19]. Also, 
oxidative stress in the vessel wall is associated with the generation of reactive oxygen and 
nitrogen species (ROS/NOS), causing vasoconstriction and impaired NO-dependent 
vasodilatation [20, 21]. All these above mentioned factors will reduce the bioavailability of 
NO and may stimulate bubble growth due to incased adhesiveness of the endothelial surface 
[3]. Subsequently, these changes will pose significant challenges and alterations on the heart -
and lung function, which will be outlined in the next sections.  
 
Cardiovascular function  
The heart is a muscular pump organized in four pumping chambers and the cardiac cycle 
constitutes of two major phases: the systolic contraction -and the diastolic relaxation phase. 
Systole is initiated when an action potential (AP) spreads along the bundle of His, the 
Purkinje fibers and transverse (T)-tubules. The complex T-tubules network ensures that the 
AP is propagated to the interior of the cardiomyocytes for synchronized Ca2+ release and 
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contraction [22, 23], which is crucial to overcome the hydraulic load imposed on the ventricle 
during ejection (afterload). When the contraction is ended, the cardiomyoctes start to relax 
and enters the diastolic phase where the myocardial wall is stretched in response to the 
hemodynamic load from the venous return (preload). Thus, the amount of blood that is ejected 
is dependent by afterload, preload and the inotropic state of the myocardium [24-26]. Since 
the human heart is adapted to a normobaric atmospheric pressure at 1 ATA, significant 
cardiovascular changes will occur during diving to ensure proper circulatory function.   
 
Cardiovascular changes during diving 
A diver faces several challenges such as increased ambient pressure and breathing gas 
density, enhanced partial pressures of gases, immersion, exercise, psychological stress, and 
thermal conditions [2, 27-30]. This elicits several cardiovascular changes such as bradycardia, 
changes in stroke volume (SV), reduction in cardiac output (CO) and increased vascular 
resistance [4, 31-35]. Bradycardia is triggered by the “diving response” through 
parasympathetic nerve activation [36, 37] but may also be attenuated by sympathetic nerve 
activation due to psychological stress [38]. While descending during a dive, increased PO2 in 
the inspired breathing gas significantly decreases heart rate [34] and induces vasoconstriction 
and hence increased systemic vascular resistance (SVR) [39]. The mechanisms for hyperoxia 
induced vasoconstriction are unclear but there are indications that the nitric oxide (NO) 
pathway is altered [40].  
 
Today no equipment exists to measure hemodynamic changes and ejection properties of the 
heart during SCUBA, thus measurements are performed after the dives or in hyberbaric 
chambers. After open sea dives, studies show a decreased SV and CO in the presence of 
increased systemic vascular resistance [4, 31, 41]. Systolic performance is not impeded only 
by an increased afterload but also due to altered diastolic function seen as a reduction in 
preload up to 2 hours after a dive [42]. One must emphasize that these measurements are 
performed after a dive and are a result of significant hemodynamic changes that have 
occurred during a dive. Although no hemodynamic data during SCUBA exist, increased 
central blood volume due to cold water immersion [43] is accompanied with diuresis [44, 45] 
and hence reduced preload after a dive. Hemodynamic changes can be seen up to 48 hours 
after a dive [4] and open sea dives are likely to increase DCS risk compared to dry dives [46]. 
This indicates that results obtained in hyperbaric chambers differ from in water dives and 
 10
more focus should be addressed to hemodynamic changes induced by immersion, exercise 
and temperature.  
 
Assessments of cardiac function in in-vivo animal studies show an increased cardiac 
contractility and left ventricular pressure under hyperbaric exposures [47-49]. This is in 
accordance with increased myocardial blood flow, indicating enhanced cardiac oxygen 
consumption (work rate) under hyperbaric pressure [49-51]. Additionally, repeated dives 
seem to induce cardiac hypertrophy since increased ventricular mass has been observed [52]. 
This is likely to suppress systolic function, as observed in the diseased heart [26] compared to 
an athlete’s heart [53], since a decreased CO is observed at high pressure [54] together with 
an altered excitation-contraction coupling [55]. Effects on the vasculature show varying 
results, where some authors do not see changes in mean arterial pressure (MAP) [48, 49] 
whereas others observe increased MAP under exposure to increased environmental pressure 
[56]. Cardiovascular changes are reported to sustain after decompression since CO, SV and 
right ventricular wall thickening decreased along with increased SVR [56]. However, it is also 
reported that cardiovascular changes are restored only a few minutes after decompression 
[48]. In order to interpret the significance of these cardiovascular changes, translation 
research is needed. Since cardiac contractile dysfunction is heavily dependent on intracellular 
Ca2+ handling and excitation contraction coupling, the next section will explain the 
mechanisms of cardiomyocyte function during systole and diastole. 
 
Excitations contraction coupling and intracellular Ca2+ handling 
 
Basic mechanisms 
The working heart is dependent on the ability of the cardiomyocytes to contract and relax. 
Contraction of the cardiomyocytes is initially activated when an action potential (AP) 
depolarizes the sarcolemma membrane and activates the process named “Ca2+-induced Ca2+ 
release” (CICR). Ca2+ enters through voltage gated L- type Ca2+ channels and results in a 
locally increase of [Ca2+]i that subsequently activates the ryanodine receptors (RYR) located 
on the sarcoplasmatic reticulum (SR) membrane [57]. RYR are  in close physical proximity to 
the L-type Ca2+ channels and it appears that each L-type Ca2+ channel controls only one RYR 
receptor [58]. A summation of individual CIRC events leads to a significant increase of 
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[Ca2+]i which in turn binds to Tropnin C on the thin filaments of the sarcomeres. This initiates 
the adenosine triphosphate (ATP) dependent cross-bridge cycling in the myofilaments and 
contraction occurs (inotropic phase) (Figure 1). After the contraction has subsided, the cardiac 
muscle enters the relaxation phase (lusitropic phase). During relaxation Ca2+ is sequestered 
within the cytostol or extruded over the sarcolemmal membrane and out of the cell. The main 
component of Ca2+ removal is the sarcoplasmatic reticulum Ca2+ - ATP-ase (SERCA2a), 
accounting for a removal of 70% in humans and 92% in rats into the SR [59]. SERCA2a is 
regulated by phospholamban (PLN); unphosphorylated PLN binds to SERCA2a and inhibits 
its activity, whereas phosphorylation removes PLN from SERCA2a and increases Ca2+ uptake 
rate. Mainly, PLN is phosphorylated by cAMP-dependent protein kinase A (PKA) at serine 
(Ser)-16 and by Ca2+/calmodulin-dependent kinase II (CaMKII) at threonine (Thr)-17 [60].  
The remaining Ca2+ is mainly removed out of the cell by the Na+/Ca2+ exchanger (NCX) [59], 
and sarcolemmal Ca2+-ATP-ase channel (PMCA), or pumped into the mitochondrial 
compartment.  
Sarcoplasmatic reticulum (SR)
RyR
PLN
L-type
L-typeCa2+
Ca2+ Ca2+
Ca2+
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PMCANCX
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Figure 1. Depiction of Ca2+ fluxes in the cardiomyocyte. This simplified version explains the parameters 
measured in paper III. Red lines show Ca2+ fluxes towards myofilaments during contraction in systole after 
depolarization of the sarcolemma, while blue lines show Ca2+ fluxes into sarcoplasmatic reticulum (SR) and over 
sarcolemma during relaxation in diastole. The following pumps, channels and proteins are involved in the Ca2+ 
fluxes: L-type; Voltage gated Ca2+ channel, NCX; Na+/Ca2+ exchanger, PMCA; Sarcolemmal Ca2+ - ATP-ase, 
RyR; Ryanodine receptor, SERCA2a; Sarcoplasmatic reticulum Ca2+ - ATP-ase, PLN; Phospholamban. This 
figure is modified from [61]. 
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Cellular changes during diving 
There are many elements within the cell that may be altered in response to changes in ambient 
pressure and hence may explain altered myocardial cell function. This includes structural 
changes of the phospholipid bilayer in the cell membrane [62, 63], ion channels and ion 
transporters and pumps [64-66] and membrane bound enzymes [67]. However, most studies 
have been performed at very high ambient pressures (> 100 ATA) in vitro to solely examine 
the effect of pressure, and significant research remains before a comprehensive understanding 
of ambient pressure effects on cellular and molecular changes during diving can be declared. 
 
High pressure seems to have both positive and negative inotropic effect on the cardiac muscle 
[64], but there is limited information how diving affects Ca2+ signaling and excitation 
contraction coupling. The contraction force seems to be transiently increased in response to 
increased pressure [68, 69] but restored to baseline values after decompression [69]. 
Previously it has been suggested that these dive induced effects may be due to altered Ca2+ 
sensitivity, SERCA2a and NCX activity [64, 66]. The positive inotropic effect may be 
explained by the increased duration of action potential observed in cardiac tissue under 
hyperbaric conditions [70], since a prolongation of the action potential may enforce a greater 
release of Ca2+ from the SR. Additionally, recordings of Purkinje fibers to 150 ATA  showed 
reduction in spontaneous beating frequency due to slowed diastolic depolarization [71]. To 
my best knowledge, there exist no studies that have studied the cellular and molecular 
mechanisms behind these observations.   
 
Cardiopulmonary function  
The entire CO from the right ventricle is carried in the pulmonary artery (PA) for gas 
exchange in the lungs. The pulmonary artery pressure (PAP) is significantly lower than the 
systemic artery pressure, which is reflected in the size and wall thickness of the right 
ventricle. In the lungs, the PA divides into numerous tiny arterioles that track along the 
alveoli, the smallest air filled components of the lung where gas exchange occurs. An efficient 
gas exchange is ensured due the high number and vast surface area of the alveoli 
(approximately 300 million and 75m2, respectively), the vast alveolar capillary bed meshwork 
and the short distance between the alveoli and the capillaries [72]. The re-oxygenated blood is 
eventually collected in the pulmonary vein (PV) and directed to the left heart. Insufficient 
lung function and gas exchange may occur due to various lung diseases that will not be 
 13
described here, but emphasis will be addressed physiological and pathophysiological events in 
response to the hyperbaric and diving environment.  
 
Pulmonary changes during diving 
During diving, proper ventilation of the lung is dependent of the ability to overcome the 
increased airway resistance and elastic loads [73]. The increased inspired gas density during 
decent is the primary factor for enhanced airway resistance and is reported to affect lung 
function by reducing forced expiratory volume, maximum expiatory flow and maximum 
voluntary ventilation [74, 75]. Additionally, increased ventilatory work may also be a result of 
the resistance of the breathing apparatus. During immersion, the elastic load (compliance) of 
the lung is heavily influenced by static lung loading (SLL), which is comprehensively 
outlined by Lundgren [76]. Both blood redistribution from immersion and body position 
(increased distance between the regulator and the chest in upright position will cause negative 
SLL, whereas the opposite occurs in head down position) will affect ventilatory work. 
Positive SLL have been reported to increase vital capacity and expiratory respiratory volume 
(ERV) whereas negative SLL seems to decrease ERV and increase dyspnea [77]. Thus, to 
minimize the work constrains of the lung and ensure proper ventilation, breathing gas is 
supplied at high pressure. However, although the breathing gas in most dives are hyperoxic, 
the most common respiratory abnormalities in diving is insufficient ventilation of the alveoli 
with a resulting hypercapnia [78]. This is due to either hypoventilation or/and elevated dead 
space and can be further reviewed in [73, 78].  
 
To ensure efficient gas exchange, the blood-gas barrier (BGB) has to be very thin but also 
strong enough to cope with high capillary pressure. These conflicting requirements may be 
problematic during diving since previously clinical symptomatic and asymptomatic 
occurrence of acute pulmonary edema (APE), such as cough, dyspnea, hemoptysis, 
hypoxemia and reduced lung diffusing capacity for carbon monoxide (DLCO), have been 
reported after swimming and SCUBA [79-82]. APE occurs as a result of increased pulmonary 
capillary permeability (non-cardiogenic pulmonary edema) or when the pulmonary capillary 
hydrostatic pressure exceeds the plasma oncotic pressure (cardiogenic pulmonary edema) 
[83]. This will subsequently lead to extravasation of fluid, cells and proteins into the 
interstitium. The exact mechanism for APE during diving is unclear, but factors such as 
increased central blood flow during immersion, cold exposure, increased PAP, increased wall 
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stress and venous gas bubbles are likely to be involved [84-86]. Although symptoms of APE 
have been reported after diving, the symptoms are in the majority of cases spontaneously 
resolved within 5 minutes to 24 hours after a dive or with β2-adrenergic agonist or diuretic 
therapy, but can also be fatal [73, 83]. Additionally, the prevalence for APE is rather rare, 
which was confirmed in a Swiss survey conducted on 1250 SCUBA divers, where only 5 
individuals out of 460 responders had a history suggestive of APE 1.1% [87]. However, 
although the susceptibility for APE is relatively low, one should have in mind that the number 
of potential individuals that could be at risk of developing APE is substantial since there are 
millions of recreational and professional divers worldwide.  
 
Environmental challenges during diving  
 
Immersion  
Although the atmospheric pressure is the same whether a dive is performed in a hyperbaric 
chamber or immersed in water, immersion causes significant hemodynamic changes due to 
the “anti-gravity” effect on the body [78]. The anti-gravity effect can also be observed on land 
where a supine position will reduce the gravity dependent pooling of blood in the legs that 
occurs in a vertical position (Figure 2). However, during immersion an increasing pressure 
from the water column in an upright posture will diminish the hydrostatic pressure in the 
veins of the lower part of the body. When the water level reaches the diaphragm (xiphoid) and 
the hydrostatic indifference point [88], there is a counterbalance between the hydrostatic 
pressure of the water and the veins of the abdomen and the lower parts of the extremities, 
offsetting pooling of blood in the dependent regions [89]. At this point, blood volume in the 
heart is almost identical as supine position on land, whereas increased water level to the neck 
increases the blood flow into the heart and thorax that leads to increased central venous 
pressure, increased diastolic filling, stroke volume and further distention of the heart [89-92]. 
The increased filling of the cardiac chambers activates cardiac mechanoreceptors which 
induces reflex adjustments of renal water and electrolyte excretion [93] but it seems that 
plasma volume, SV and CO remain elevated throughout 6 to 12 hours of immersion [43].  
 
During diving the effect of immersion is prominent but will naturally differ dependent of the 
duration of the dive. However, another aspect that is of great importance is the effects on the 
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cardiovascular system after immersion. After immersion, hemodynamic effects such as 
reduced preload and CO, have been reported to be sustained for up to 16 hours after 
immersion [94], while several cardiac changes are not fully reversed up to 48 hours after 
SCUBA [95]. Until now there is sparse data that describe the long term cardiovascular effect 
of immersion and physiological performance in the recovery phase after immersion.  
 
 
 
Figure 2. Depiction of blood distribution at different body positions in air and during water immersion. Upper 
left shows a person in vertical position on land where blood pressure is highest in the legs due to gravity. Upper 
right shows a person in a supine position on land where more blood is allocated to the heart/thorax. Bottom left 
shows a person vertically immersed to the neck where gravity is abolished and more blood is allocated to the 
heart/thorax. Bottom right shows a SCUBA diver with approximately the same blood distribution as vertical 
immersion.  Made by MGS studios.   
 
Temperature 
Thermal problems, whether it is hyperthermia or hypothermia, and especially the latter, is a 
well known problem in diving. Hyperthermia is most likely to occur in waters above 
thermoneutral temperature (34-35 ºC) [93]  or in hot water suits [96], but since most of the 
waters in the world are below human thermoneutral temperature, this section will focus on  
diving in cold environments. Due to the high thermal conductance and capacity of water [97], 
diving imposes great demands on the human thermoregulatory system. The metabolism 
increases in proportion with the reduction in skin and core temperature [98] as a result of the 
depth and duration of the dive and the status of thermal protection.  
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Diving in cold conditions is believed to increase the risk of DCS [99]. The mechanisms are 
still unclear but since gas uptake and removal are primary determent by perfusion [100], cold 
induced vasoconstriction through sympathetic nerve activation [45] is likely to have a 
significant effect on the outcome of a dive. There have been observed fewer incidences of 
paresthesia, pruritus and skin rash in areas of skin with added thermal protection [101] and 
according to U.S Navy dive procedures, longer decompressions are required when the divers 
are exceptionally cold during a dive [102]. Additionally, during diving it is beneficial to have 
an optimal thermal status at different phases of a dive and specifically it has been observed 
that cold conditions at the bottom time and warm conditions during decompression and post 
diving reduces DCS risk [103-105]. The opposite situation, which is the case in most dive 
scenarios, with warm conditions during bottom time and cold during decompression should 
result in increased perfusion and gas uptake at the bottom and less perfusion and prolonged 
duration for desaturation of nitrogen during decompression [30]. Technical approaches with 
heated undergarments could prevent the latter situation, but at this point this not widely used 
due to high costs and insufficient technical quality. Although there is some literature 
regarding diving and cold temperatures, there is no solid evidence providing a causal 
relationship between temperature and dive risk [29, 99]. Thus, to improve dive safety, 
comprehensive knowledge regarding cold water diving is needed and will be of increasing 
interest due to the rapid expanding activity in the northern areas.  
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Aims and hypotheses 
The main purpose was to examine dive induced cardiopulmonary changes through a 
translational perspective in order to obtain a more comprehensive understanding of human 
adaptations and responses after dive under various environmental conditions. The specific 
aims were: 
 
I. To determine the significance and duration of acute interstitial lung edema after 
SCUBA with the hypothesis that asymptomatic acute pulmonary edema will 
disappear within 2-3 hours after SCUBA in healthy individuals. 
 
II. a). To continuously investigate cardiovascular changes at all time points during a    
dive with the hypothesis that cardiovascular changes observed after a dive is a 
result of hemodynamic changes occurring at all time points during a dive and not 
solely during the decompression phase.  
 
   b). To determine the effect of cold exposure during decompression and post dive   
on bubble grade and DCS risk with the hypothesis that cold decompression and 
post dive period will decrease off-gassing and hence increase bubble production 
and DCS. 
 
III. To determine the effect immersion prior to a dive had on cardiomyocyte function 
and DCS risk with the hypothesis that immersion induces prolonged 
cardiovascular changes that will promote bubble production and DCS risk. 
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Methodological considerations  
 
Animal protocols 
In study II & III Sprague Dawley female rats were used. We chose this strain and gender 
since our research group has considerable experience in using these rats in hyperbaric 
experiments [106-109]. The experimental protocols were approved by the Norwegian 
Council for Animal Research, and all experimental procedures conformed with the 
European Convention for the Protection of Vertebrate Animals used for Experimental And 
Other Scientific Purposes.  
 
Human trial 
All experimental procedures were conducted in accordance with the Declaration of Helsinki, 
and were approved by the Ethics Committee of the University of Split School of Medicine. 
Each method and potential risks were explained to the participants in detail and they gave 
their written informed consent before the experiment. The participants were experienced 
divers of the Croatian Search and Rescue Unit (CRS). No subject developed decompression 
sickness (DCS), but in case of emergency the dive site was in close proximity to a 
recompression chamber.  
 
Ethical considerations  
The purpose of the animal experiments was to obtain improved knowledge of biological and 
medical issues related to human or animal health. In study II & III we used animals to obtain a 
more comprehensive understanding of cardiovascular events that have been reported after 
SCUBA diving. We always strive for alternative solutions that do not involve animals but 
when animal experiments are the only alternative we ensure proper animal welfare by 
focusing on the three R’s  - replacement, reduction and refinement [110].  
 
The human trial in study I showed bubble grades up to grade IV, but there was a considerable 
difference in bubble production between the individuals. This raises an ethical dilemma, 
should we advise the “high bubblers” not to dive? Obviously today’s decompression 
 19
procedures are not good enough, but the only way to improve dive safety is to increase our 
knowledge. This can be done by performing controlled human trials. Study I was done in 
collaboration with the Split Medical School in Croatia due to their vast experience on human 
dive trials [4, 41, 46, 95, 111]. Some people may disagree and claim that we should terminate 
this testing, but we mean on the contrary, it is unethical not to continue. Since the millions of 
divers use the guidelines made by researchers, we must validate and be certain that our 
recommendations are reliable.   
 
Dry hyperbaric diving 
The most used approach is to expose animals to diving conditions in simulated dry dives in a 
hyperbaric chamber. The chamber is easily pressurized and de-pressurized with air and hence 
tightly controlled dives can be performed.  Although certain elements such as e.g. immersion, 
water current, exercise and temperature differ from open water dives, physiological and 
cellular adaptations to high atmospheric pressure can be elaborated. In the non-anesthetized 
rats in study III, we used a dive profile that has previously been widely used in our group 
[107, 108, 112]. This protocol is appropriate to study individual response to diving since 
female rats at 270-300 grams get both high bubble scores (grade 3-5) or low bubble scores 
(grade 0-2). A less stressful dive would not induce significant physiological responses and 
thus it would be impossible to target the mechanisms behind the vast interspecific discrepancy 
in bubble production and DCS risk. In study II however, rats were exposed to a less stressful 
dive since pilot studies and unpublished work (Jørgensen et. al) have shown that anesthetized 
animals are more prone to bubble production and DCS risk. To minimize possible anesthesia 
induced effects such as insufficient gas exchange, altered breathing pattern and thermal status, 
we performed several pilot studies to ensure that spontaneous breathing rats on an electric 
heat pad had normal blood gas values throughout the experiment. Since the purpose of this 
paper was to observe dynamic cardiovascular changes at different core temperatures during a 
dive, it was crucial that the rats survived the dive protocol. The decompression procedures 
and interventions are more thoroughly described in the papers.  
 
Open seawater diving 
Field studies require a great deal of logistics and planning. In the trimix field study we 
established a fully equipped field laboratory in proximity to the dive site. When entering the 
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laboratory, the divers had to follow a tightly controlled schedule which enabled rapid and time 
matched measurements. The participants had a professional attitude and considerable dive 
experience which is of importance when analyzing and evaluating individual human response 
to diving. Due to similar skill levels, factors such as buoyancy control and physiological stress 
were minimized. Decompression profiles were determined using V-planner software 
according to Varying Permeability Model (VPM-B) [113]. During the dive, breathing 
mixtures of O2 (16-17%), He (44-46%) and N2 (37-39%) (trimix) were used up to 21 m. At 21 
m the divers changed from trimix to nitrox mix (50% N2/50% O2) in order to keep the partial 
pressure of oxygen (PO2) at 160 kPa [114]. Exceeding the recommended levels of [PO2] can 
lead to several toxic effects that may lead to fatal events [40].  A group leader validated the 
gas mixtures in each diver and controlled the decent rate, duration of the dive and 
decompression rate. Each dive profile was downloaded from the computers and used to 
calculate the probability of DCS (PDCS) as an index of severity of exposure [115].   
 
Bubble detection and analysis 
Compared to ultrasonic Doppler measurements which can be challenging in respect to proper 
monitoring and analysis [5], ultrasonic imaging is a well suited and cost-effective technique 
for detection of decompression bubbles even for personnel with limited previous experience 
[116]. The 2- dimensional (2D) ultrasonic scanning (B-mode imaging, brightness mode) is 
today the most widely used imaging technique for detection of intravascular gas bubbles 
[117].   In all studies, decompression bubbles from 2D ultrasonic images were graded from 0 
to 5 according to the following criteria:  0 = no bubbles; 1 = an occasional bubble; 2 = at least 
one bubble every 4th heart cycle; 3 = at least 1 bubble in each heart cycle; 4 = continuous 
bubbling, at least one bubble/cm3 in all frames; 5 = individual bubbles are absent (“white-out) 
and are most often seen animals [5] and only once reported in humans [118]. 
 
Vascular bubbles observed after decompression are most likely formed on the venous side 
(VGB) of the circulation due to higher gas tension and lower blood pressure than the arterial 
side [3, 8]. VGB will pass the right ventricle (RV) and pulmonary artery (PA) for gas 
elimination in the lungs and therefore we imaged VGB as high intensity echoes in the RV and 
the PA [119]. To make sure that we measured the correct number of VGB, 2D scanning was 
performed for at least 30 seconds with a transducer at 10 MHz frequency in study II & III and 
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1.5-3 MHz frequency in study I. Previous experience has shown that these frequencies give 
the best penetration and resolution in the investigated structures. 
 
The main challenge using 2D scanning is to obtain high quality images with accurate VGB 
scores [117]. The pulmonary circulation is a well suited detection area but there may be a 
chance that we underestimate that actual number of gas bubbles since some bubble may be 
trapped as stationary bubbles. Although Daniels et al [120] have developed a technique to 
measure stationary and moving bubbles with high resolution ultrasound imaging, the method 
is not developed further, and can therefore not obtain accurate and reliable  measurements of  
stationary bubbles. Recently, a technique named Second-order UltRasound Field Imaging 
(SURF) [121] shows promising results in improving ultrasound imaging and may be well 
suited for future detection of stationary decompression bubbles.  
 
Cardiomyocyte isolation and measurements 
In cardiovascular research cardiomyocyte measurements are widely used to study cellular 
function of the left ventricle (LV). This is in contrast to dive related research where cellular 
data to support in vivo findings are limited. Cardiac changes from diving have been observed 
in man [4, 31, 42], and in order to understand the mechanism behind these observations we 
isolated cardiomyocytes from the LV. Immediately after the dive protocol was ended in study 
III, the hearts were quickly put into ice-cold Krebs buffer to prevent hypoxic events and 
connected to the aortic cannula of a standard Langendorff retrograde perfusion system as 
described in [122]. To ensure stable physiological conditions, the hearts were perfused with 
Krebs buffer and collagense at a rate of 7,5ml/min. After proper digestion of the myocardium, 
cardiomyocytes from the LV were isolated and deposited on coverslips for cell measurements. 
Contractile properties and Ca2+ handling were recorded by electrically stimulating the cells on 
an inverted epi-fluorescence microscope (Nikon eclipse – TE 2000-S, Tokyo, Japan). To 
avoid bias and only use healthy cells, rod shaped cells without blebs or other visible 
morphological damages were tested to 2 Hz before recordings started. In study III all 
measurements were obtained at room temperature at 2 Hz.  
 
The FURA-2AM is a high affinity Ca2+ indicator that responds to Ca2+ by shifting 
wavelengths while maintaining strong fluorescence. The fluorescent signals from FURA-
2AM are obtained by exciting the cardiomyocytes at a wavelength at 340 nm and 380 nm 
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with an emission wavelength at 510 nm. The ratiometric fluorescence intensities detected at 
510 nm give an estimate of the intracellular Ca2+ levels in the cardiomyocytes [123]. Since 
this is a sensitive fluorescent dye that may affect cardiomyocyte shortening [124], loading 
was performed under the same environmental conditions: i.e 20 minutes at room temperature 
in a dark room with a FURA-2AM concentration of 2 µM.  
 
Protein analysis  
Western immunoblotting, a semi-quantitative technique for protein detection, was performed 
to support our cardiomyocyte measurements. Western blot is a reliable and common stepwise 
technique where proteins are separated on the principle of gel-electrophoresis. Next, the 
proteins of interest can be detected by adding specific antibodies. In study III we examined 
proteins known to be involved in Ca2+ handling during diastole. Protein expression levels 
were measured in isolated cardiomyocytes instead of a tissue sample prior the isolation. 
Although a tissue sample would have gained more protein than isolated cardiomyocytes and 
hence facilitated the protein analysis, we wanted to measure protein expression under the 
same conditions as the actual recordings were performed. Protein analysis was performed by 
an Italian collaborator due to the difficulty in performing western blots on low protein 
amounts. The protein analysis protocol is further described in paper III.   
 
Pressure volume loop (PV-loop) analysis 
During the cardiac cycle pressure is generated and ejects a volume of blood [26], following 
the Frank-Starling Law of the Heart [125, 126]. Accurate assessment of systolic and diastolic 
ventricular function is possible via PV-loop analysis [24]. Study II investigated left 
ventricular (LV) mechanical properties with a Millar PV-loop catheter and this section will 
explain hemodynamic events from the LV. A 2.0 French catheter was used (designation of the 
spacing between the sensors of the record unit (9 mm)). We experienced that this is the 
maximal catheter size that should be used to obtain reliable volume signals without the sensor 
tip exceeding the internal ventricle length in rats of 240-280 grams. Additionally, one Millar 
catheter was inserted into the left femoral artery to measure mean arterial pressure (MAP). 
The catheter insertion into the LV is a sensitive technique and pilot studies showed that 
increased ambient pressure could result in compression of the chest and thus the sensor tip 
touching the myocardial wall. To ensure reliable PV-loop recordings, the catheter tip must at 
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all times be in the center of the ventricle without touching the myocardial wall and 
experiments that did not meet this inclusion criterion were not included in the study. 
 
Figure 3 illustrates the instrumental setup and PV-loop diagram (bottom right). At point A, 
the onset of systole, depolarization of the heart occurs initiating the isovolumic contraction. In 
this period left ventricular pressure (LVP) rises with unchanged volume, mitral valve closes 
while aortic valve is also closed due to higher aortic pressure (AoP). At point B, LVP exceeds 
AoP, the aortic valve is opened and blood is ejected until the heart reaches the maximum 
activates state at point C. Ejection is now ended and the heart enters isovolumic relaxation, 
where LVP declines at a constant left ventricular volume (LVV) due to closed aortic –and 
mitral valve. At point D, filling of the ventricle begins when LVP decreases atrial pressure 
and hence mitral valve opens. By analyzing changes in the shape of the PV-loop diagram 
during the cardiac cycle, we were able to assess how pressure changes in diving affects the 
cardiovascular system. Detailed description of analysis procedures is available in Burkhoff et 
al [24].      
 
 
 
Figure 3. Depiction of the pressure volume loop (PV-loop) recordings in an anesthetized rat. By inserting a  
Millar catheter into the left ventricle and femoral artery, recordings of cardiovascular changes in response to 
hyperbaric exposure at different temperatures are possible. Made by MGS studios.  
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Assessment of pulmonary edema 
Measurements of pulmonary function consisted of spirometry and single breath lung diffusing 
capacity for carbon oxide (DLCO) pre –and post diving. DCLO is a technique to measure gas 
diffusion between the alveoli and the blood and can be viewed in detail in paper I. DCLO is 
reduced when fluid is redistributed from the capillary lumen into the alveolar interstitium, an 
event that leads to acute pulmonary edema (APE) [127, 128]. Based on previous reports that 
have shown reduction in DLCO up to 60-80 minutes after dives [41, 82], we wanted in study I 
to evaluate if pulmonary depression was persistent for several hours after dives. Since there is 
a large variation in individual physiological response to diving, each diver was tested in the 
same order and time point after each dive.   
 
Chest x-ray is the gold standard to assess extravascular lung water (EVLW) but it is 
inappropriate for field studies due to the need of radiology facilities and specific reading 
expertise [129]. Therefore, in study I we examined the lung for the presence of extravscular 
lung water by counting the number of ultrasonic lung comets (ULC) [130] with a portable 
ultrasonic scanner (Vivid i). The ULC, generated by the difference in acoustic impedance 
between air and water, is defined as an echogenic, coherent, wedge-shaped signal with a 
narrow origin arising from the hyperechogenic pleural line and extending to the far edge of 
the viewing area.  Although the lung is considered poorly accessible to ultrasound, images of 
ULC for EVLW measurements have been proven to correlate well with other methods 
including chest x-ray, computerized tomography (CT) and thermodilution [129, 131, 132]. 
The number of ULC were assessed from 61 predetermined chest sites on the anterior and 
posterior chest wall [133] and expressed as the sum of all chest scanning areas. The 
reproducibility of our approach was tested by performing the ULC assessment at two time 
points in the same day in absence of a dive.  
 
Cardiac function by echocardiography and blood samples 
Thorough examination of both right and left ventricles was examined by 2D 
echocardiography pre –and post dive according to the previously described protocol [95]. 
Since there is limited information available regarding consecutive trimix diving, bubble 
production and DCS risk, cardiac measurements were critically evaluated along with bubble 
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score and ULC before and after each dive. Based on these continuous measurements none of 
the divers were excluded from the study. 
 
Paralleled with the non-invasive methods to assess dive induced cardiopulmonary strain, 
quantitative protein concentrations in blood of N- terminal pro-brain natriuretic peptide (NT-
proBNP) and pro-atrial natriuretic peptide (proANP) were analyzed with highly protein 
sensitive commercial immunoassay kits. The blood samples were taken approximately one 
hour after the dives,  thus NT-proBNP was chosen over BNP since the half-time of NT-
proBNP is longer than BNP [134]. Also, due to NT-proBNP and proANP’s effect in 
electrolyte and volume homeostasis [135, 136] and hence dehydration following the dives, the 
amount of peptides was corrected for increased albumin concentrations.  
 
Statistics  
In both study II & III data have been presented as mean ± standard error of the mean (SEM), 
while in study I we presented mean ± standard deviation (SD). In paper III a one way 
ANOVA test using LSD as post-hoc test was used to evaluate the cardiomyocyte parameters 
in the different groups. For evaluating the differences in bubble formation, a Mann-Whitney 
U test was used as in paper II, while Friedman test was used in paper I. In study II, 
comparisons between the groups in respect of hemodynamics and blood parameters were 
performed with two-tailed independent Student’s test. In study I, after normality of the 
distribution was confirmed for all parameters using Kolmogorov-Smirnov test, pre –and post 
dive values for a single dive were assessed by Student’s test for paired samples. We evaluated 
the changes from baseline values and response to diving at different time points by repeated 
measures ANOVA with Dunnett’s test in study II and with Bonferroni post hoc test in study I. 
Differences were considered significant at P<0.05.  
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Results and discussion  
  
The present thesis reports that both in vivo and cellular data from animal studies are of great 
importance to obtain a comprehensive understanding of the dive induced cardiopulmonary 
changes seen in humans (Study I-III). In most cases it seems that diving induces transient 
changes since symptoms of EVLW and cardiac strain in study I came back to baseline values 
between repetitive dives and in study II where cardiovascular parameters came back to 
baseline after the dive exposure. However, environmental factors such as temperature and 
immersion are likely to induce prolonged effect on the cardiovascular system since in study II 
SV and CO significantly dropped after rewarming whereas in study III the effect of 
immersion significantly influenced upon the outcome of a subsequent dive.  
 
Hemodynamic changes and impact on venous gas bubble 
production 
The vast individual variation in susceptibility for bubble production and DCS after identical 
dives indicates that some individuals are better adapted to diving than others. Since there is 
also an intra-individual difference in bubble production after identical dive procedures, it is 
likely that daily physiological status plays a significant role. Even in animal studies, where 
physiological parameters are tightly controlled, there are big intra –and inter-specific 
differences. Thus, to minimize influence from external factors, the divers had to strictly 
follow the same procedures. It was emphasized that the divers had to restrain from exercise 
before diving, during decompression and after the dives since these conditions have been 
reported to reduce venous gas bubbles after dives [137-139]. In recent years, especially 
exercise prior to a dive has gained a lot of attention due to its precondition effect on bubble 
production [106, 137, 140]. The exact mechanisms are unclear but it is strongly believed that 
exercise influences bubble production through the nitric oxide (NO) pathway [106, 107] and 
thereby reducing the probably of nuclei adhering to the endothelium [3]. The most effective 
precondition effect has been reported after strenuous exercise 24 hours before a dive. 
Although rats in study III were faced very light swimming prior a dive, a possible exercise 
induced effect was offset by the time point and magnitude of exercise and the significant 
effect of immersion. However, in study I the divers performed moderate exercise during the 
bottom phase (up to 40% of max HR) while abstaining from exercise during decompression 
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stops. Exercise alters the blood flow to body compartments with increased perfusion of the 
skeletal muscles [141, 142]. Perfusion is recognized to be the main factor affecting uptake and 
removal of inert gas [100], thereby controlling bubble production and DCS risk. This 
implicates that the trimix divers had increased gas uptake during bottom time while reduced 
gas elimination during decompression. This may have contributed to increased bubble 
production since increased work load during decompression is proven to reduce venous gas 
bubble production [138, 143].  
 
During diving, hemodynamics are affected by additional environmental factors such as 
immersion and cold temperature which may influence upon the increased bubble production 
seen after open sea dive versus dry hyperbaric dives [46]. Thus, this indicates that dry dive 
protocols should not be directly implemented into wet dive protocols. It is well known that 
immersion has an anti gravity effect which leads to increased central blood volume but there 
is sparse information regarding the long term effects of immersion and why wet dives produce 
more bubbles. In study III we observed that a hyperbaric exposure preceded by one hour 
immersion depressed heart function and increased mortality and bubble production after 
decompression. Since there was no significant drop in core temperature, the changes were 
likely due to hemodynamic changes. One could only speculate why this will produce more 
bubbles but the increased blood flow could impose mechanical shear stress and hence 
detachment of bubbles from the vessel wall. Additionally, immersion induced hypervolemia 
could be the cause of increased release of pro-atrial natriuretic peptide (proANP) in the trimix 
divers, which is often paralleled with increased naturesis and diuresis [93, 144]. This could 
alter the surface tension in the blood and promote bubble grown since a decreased surface 
tension is likely to stimulate bubble growth [145].  
 
Based on previous studies that report increased bubble production and risk of DCS under cold 
conditions and cold decompression [104, 105], we carried out study II to investigate how 
cardiovascular function continuously changes during a dive at different temperatures and what 
impact these changes have for the outcome of a dive. Our study mimicked a dive scenario 
where the divers are constantly warm (W/W) or become cold during decompression and post 
dive (W/C), but our results showed no significant increase in bubble production and DCS risk 
where cold decompression was present. Thus, our finding do not support the hypothesis that 
cold decompression should result in decreased perfusion and off-gassing and hence increased 
bubble production [30], but are in line with others who state that there are no solid evidence 
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demonstrating a causal relationship between temperature and diving [29, 99]. However, one 
should have in mind that our study was performed on anesthetized rats under dry hyperbaric 
conditions and were not affected by immersion and exercise that are know to affect perfusion 
and bubble production [46, 146]. We chose a maximum reduction in core temperature of 2ºC 
in the rats since a core temperature below 35 ºC is defined as accidental hypothermia in 
humans [147, 148], but due to species differences a 2ºC temperature drop may not be that 
critical for rats. In study II we observed no cold induced vasoconstriction since mean arterial 
pressure (MAP) and total peripheral resistance (TPR) did not differ between the experimental 
groups during decompression and post dive. This indicates that perfusion was not restricted 
and inert gas removal in the W/C group followed the same pattern as in the W/W group. Our 
results are in contrast  to Mack and Lin [30] who found a significant reduction in nitrogen 
elimination and washout rate constant (k) in hypothermic unanesthetized rats (33 ºC). The 
contrary results may be due to various physiological effects of anesthesia. Anesthesia is 
known to offset the thermoregulatory control and induce hypothermia [149], but since the rats 
in our study were heated on an electrical heat pad we were able to maintain constant core 
temperature. During core cooling, the lack of vasoconstriction may be due to the initial 
anesthesia induced vasodilation facilitating core to peripheral redistribution of blood [150] 
and since we had a short observation period the subsequent thermoregulatory vasoconstriction 
did not occur.      
 
The significance of dive induced asymptomatic pulmonary edema  
Based on previous reports that have observed asymptomatic signs of APE such as EVLW and 
reduced DLCO after diving [82, 85], study I was carried out to evaluate the persistence of 
EVLW by ULC measurements. We found that EVLW returned to baseline values between the 
dives and was resolved within 2-3 after each dive, which is in contrast to [85] where EVLW 
did not return to baseline during the course of repetitive dives. Due to the limited number of 
studies and since APE is only reported with a prevalence ranging from 1.1% to 1.8 % in 
swimmers and divers [81, 87], the physiological mechanisms contributing to this phenomenon 
are still unclear. A key factor may be immersion induced increase in venous return, resulting 
in 700 mL increased intrathoracic blood volume during head out immersion which 
corresponds to the PAP increase of 12 mmHg [91]. Consequently this may lead to increased 
pulmonary blood volume and transmural capillary pressure that may lead to capillary stress 
failure, extravasation and alveolar fluid flooding [151]. Symptoms of EVLW (swimming 
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induced pulmonary edema) have also been observed in studies conducted on swimmers and 
triathletes [81, 152]. The central pooling of blood is reinforced due to cold-induced peripheral 
vasoconstriction which further contributes to ANP secretion and increased vascular 
permeability [153]. In our study cold was probably a minor effect since divers faced a 
minimum water temperature at 14-15 ºC in well insulated dry suits. However, the divers had 
to perform moderate exercise to overcome various water current velocities which may be of 
importance since strenuous exercise increases pulmonary blood flow and may promote 
pulmonary edema [154]. In addition to the aforementioned factors that could affect EVLW 
and the pulmonary circulations is hyperoxia, which can induce pulmonary inflammatory 
responses and endothelial damage that will contribute to interstitial edema [155, 156]. 
Demchenko et al. [156] observed that even hyperoxic breathing <1.5 ATA resulted in 
destruction of the alveolar-capillary barrier and edema and this scenario could have occurred 
in the trimix divers who were exposed to a breathing gas with O2 partial pressure up to 150 
kPa. They did not exceed the recommended levels of [PO2] since that can lead to several toxic 
effects that may lead to fatal events [40]. 
 
In the trimix study, venous gas bubbles were seen after each dive and this may contribute to 
development of APE due to pulmonary microembolisations that cause inflammatory 
responses and breaks in the thin capillary endothelial layer [14, 15, 56]. This could lead to 
blood redistribution and overperfusion of pulmonary capillaries in dependent regions, which 
is in close resemblance to the inhomogeneous hypoxic vasoconstriction occurring in high-
altitude PE [151]. Previously, venous gas bubbles have been seen in parallel with increased 
PAP [85] and reduced DCLO [41, 82] but the significance of bubbles are unclear since we 
found no correlation between bubbles and APE. The discrepancy may be due insufficient 
bubble detection but also to the time points for DCLO measurements. It has been shown that 
reduced DCLO lasts for up to 80 minutes and our recordings of unchanged DCLO at 120-180 
minutes indicate that physiological signs of symptomatic APE are transient. However, 
although we found no spirometric decrements, Skogstad et al. [157] found a reduction in 
spirometric parameters for up to two hours after dives to 10 and 50 meters. The reason for this 
discrepancy is unclear and thus further research is needed to evaluate the significance of 
asymptomatic APE under different dive protocols.  
 
Finally, since the EVLW accumulation is affected by the dive induced left ventricular changes 
seen in all the paper in this thesis, one must consider the significance of the observed cardiac 
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changes for EVLW buildup. The observed decrease in left ventricular EF and FS along with 
increased end-systolic volume (ESV) and end-diastolic volume (EDV) in study I are 
indicative of reduced left ventricular contractility, which was also observed in the 
cardiomyocytes in study III. Increased LV EDV and end-diastolic pressure (EDP) could 
facilitate EVLW since this would result in increased LV atrium pressure that propagates into 
the pulmonary circulation and hence induces edema. However, since we did not see an 
increase in LV EDP in the rats in study II, implying that PAP was unchanged, edema was 
most likely less prominent in this study. These contrary results have also been seen in other 
studies where increased PAP is found after open sea dives [4] whereas no increase in PAP is 
found after dry dives [158].  
 
Dive induced changes of left ventricular function  
In this thesis dive induced LV changes were examined from a translational research point of 
view. Study I examined changes in humans after a dive, study II examined changes during the 
whole time span of a dive in an in vivo animal model, whereas study III examined some of the 
cellular mechanisms behind the cardiac changes. The divers in study I showed signs of 
cardiac strain due to increased plasma levels of NT-proBNP and proANP and reduced LV 
function (Table 1). The trimix divers maintained constant core temperature during the dive 
but when compared to the rats with constant core temperature in study II (W/W), cardiac 
parameters differed significantly. Study II was performed under dry hyperbaric conditions and 
all recorded cardiac parameters in the W/W group returned to baseline post diving, indicating 
pronounced immersion induced hemodynamic changes in the human trial. Likely, 
centralization of blood resulted in increased wall stress (increased proANP and NT-proBNP) 
but also increased EDV (preload). Due to the Frank-Starling relationship [125, 126], increased 
preload should normally increase the volume of blood ejected during the systole. However, 
this refers to a healthy heart at normobaric pressure. Our study along with previous findings 
shows that diving is also associated with increased ESV [85, 95], indicating that an increased 
preload is not necessarily correlated with increased SV. We report no change in SV which is 
contrary to previous observations after air SCUBA dives [4, 31]. The reason for our 
observation is unclear but may be due to successful rehydration at the time of ECHO 
assessment (120-180 minutes after the dive). In addition to preload, SV is determined by 
afterload and the inotropic state of the myocardium. Human trials give valuable information 
how heart function is altered after a dive, but it does not give us the whole picture of diving 
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since several important changes may have occurred prior to the measurements and at the 
cellular level.  
 
Table 1. Parameters of left ventricular function. 
           Dive 1            Dive 2           Dive 3 
 Predive Postdive Predive Postdive Predive Postdive 
FS, % 35.3 ± 1.8 34.0 ± 1.5† 36.0 ± 0.6 33.6 ± 1.3* 36.0 ± 1.2 33.1 ± 1.1* 
EF, % 64.1 ± 2.6 62.4 ± 2.0 65.2 ± 1.0 62.3 ± 1.4* 65.4 ± 1.5 61.7 ± 1.2* 
SV, ml 73.7 ± 10.6 76.9 ± 12.0 76.5 ± 12.3 74.7 ± 12.4 74.9 ± 12.8 75.9 ± 12.6 
EDV, ml 114.4 ± 16.7 123.1 ± 
20.3* 
117.3 ± 18.9 106.3 ± 27.6 114.4 ± 19.4 123.2 ± 
19.7* 
ESV, ml 40.9 ± 6.9 46.3 ± 8.6* 41.0 ± 6.8 45.0 ± 6.7* 39.6 ± 6.9 47.2 ± 7.1* 
HR, bpm 61.1 ± 6.9 66.6 ± 6.7 64.0 ± 4.2 66.1 ± 8.2 64.0 ± 5.0 67.6 ± 9.2 
CO, l/min 4.5 ± 0.7 5.1 ± 0.6* 4.9 ± 0.6 5.0 ± 1.0 4.8 ± 1.0 5.1  ± 0.7 
 
The performance of the left heart was evaluated ultrasonographically before diving and 120-180 min after 
surfacing. FS; endocardial fractional shortening, EF; ejection fraction, SV; stroke volume, EDV; end-diastolic 
volume, ESV; end-systolic volume, HR; heart rate, CO; cardiac output. *P<0.05 versus baseline value obtained 
on a same day. † = 0.078 versus Predive on the same day.  
 
The cellular data in study III may give a more comprehensive understanding of the reduction 
in left ventricular contractility in study I (decreased FS and EF). In rats exposed to immersion 
prior to a dive we observed a decreased cardiomyocyte shortening (% contractility) in the 
presence of increased intracellular systolic [Ca2+] and [Ca2+] amplitude (Figure 4 A-C). 
Normally decreased shortening is paralleled with insufficient systolic [Ca2+]i, since failing 
cardiomyocytes have reduced contractility [122, 159] and since [Ca2+]i - amplitude is strongly 
correlated with cardiomyocyte contraction [160]. However, an increased [Ca2+]i appears to be 
involved in the short- and long term compensatory mechanisms maintaining CO in 
physiological and pathological conditions, but an inappropriate excess of [Ca2+]i may 
eventually contribute to heart failure [161]. In our study there may be two plausible 
explanations for depressed contractility in the presence of high [Ca2+]i; 1) Since we did not 
measure cardiomyocyte length, the cardiomyocytes might be slightly pre-contracted prior to 
recording and thus further contraction was impaired  and/or 2) the Ca2+ sensitivity may be 
reduced. The mechanisms behind altered Ca2+ sensitivity are complex and not fully 
understood, but in failing hearts multiple biochemical alterations of the contractile proteins 
including changes in the Troponin complex (TnT, TnC, TnI) [162], suppression of α and 
increased β-myosin heavy chain expression [163] have been reported.  
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Figure 4. Systolic parameters in cardiomyocytes electrically stimulated at 2 Hz. White bars represent control 
animals. Black bars represent dry hyperbaric dive. Striped bars represent dry dive preceded by immersion. A: 
Cell shortening (%). B: Intracellular systolic [Ca2+]. C:  [Ca2+] Amplitude. 
 
The increased diastolic [Ca2+]i, increased diastolic relaxation time and altered protein 
expression levels in study III (Figure 5 A-F) may address cellular explanations of depressed 
LV function in study I and previous reported impairment of diastolic function up to 2 hours 
after dives [31, 42]. Although study III investigated the physiological effects of immersion 
prior to a simulated dry dive, the findings can be related to the studies evaluating the effects 
of immersion during SCUBA diving. Of specific interested is the duration of immersion 
induced changes, since study III showed that the effects were present after getting out of the 
water. Study I showed impaired LV function up to 3 hours after a dive, and Boussuges and 
colleagues have shown that hemodynamic changes did not return to baseline values 16 hours 
after prolonged water immersion [94]. The sustained immersion induced allocation of blood 
to the heart and thorax [78, 89]  with increased stretch of the myocardial wall due to increased 
EDV during diving may be the cause for impaired diastolic function. Figures 5 A-F show 
important cellular determinants for cardiac muscle relaxation and underlines that diastolic 
function is significantly depressed after diving. Prolonged relaxation is well described in 
failing hearts and may be partly explained by reduced protein levels of SERCA2a and 
decreased phosphorylation of PLN [164]. However, reduced SERCA2a activity seen in study 
III will normally lead to reduced re-uptake of Ca2+ into SR during diastole and subsequently 
lower Ca2+ SR-content and Ca2+ amplitude. Additionally, in the rats exposed to immersion 
prior to a dive we observed  increased diastolic [Ca2+]i due to reduced reuptake of Ca2+ into 
the SR (Figure 5 D&F) and/or leakage through RYR [165, 166] and may be a explanation for 
reduced LV function since increased diastolic [Ca2+]i is reported to enhance myocardial 
stiffness [167]. Since there is sparse information on how diving alters Ca2+ signaling in 
cardiomyocytes, further studies are needed to verify these results. The results from both 
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studies I and III indicate that immersion has a significant effect of LV function, but at this 
point we can not elaborate about the significance of the changes. 
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Figure 5. All figures represent diastolic properties in cardiomyocytes electrically stimulated at 2 Hz. * refers to 
significant difference between dry dive and control. # refers to significant difference between pre-immersion 
dive and control. Upper panel; A: time to baseline (T50 relaxation, ms), B: [Ca2+] decay (T50 decay, ms), C: 
Intracellular diastolic [Ca2+] levels. Lower panel; D: protein levels of sarcoplasmic reticulum calcium ATPase 
(SERCA2a), E: protein levels of Na+/Ca2+ exchanger (NCX) and F: phosphorylation of phospholamban (PLN).  
 
 
Human trials report increased ESV, ESP and TPR resistance after diving [4, 33, 85]  and these 
changes are good indicators of increased afterload. Clinical trials probably give the most 
correct assessments to evaluate human physiological adaptations to SCUBA, but today’s 
technology is not suitable for underwater measurements. This results in a lack of valuable 
measurements during the dive and thus we initiated the in vivo study to evaluate at which time 
point crucial cardiovascular changes occurred and if these changes could be of importance for 
interpreting the observed changes after a dive. In study II we observed that the most 
conspicuous cardiovascular changes occurred during bottom time before gradually declining 
during decompression and returning to base line post diving. From figure 6 A-C it was 
apparent that afterload was significantly increased, underlining that increased atmospheric 
pressure mainly impaired LV systolic function and hardly LV diastolic function under dry 
dive conditions. The increase in afterload was likely due to increased [PO2], causing well 
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known hyperoxia induced vasoconstriction [21, 168]. As seen in figure 6B, this affected 
ejection of blood from the LV and since HR remained unaltered, reduced CO was due to 
reduced SV (Figure 7 A). This is in accordance with previous reports [27] stating that 
decreased CO was due reduced SV under dry hyperbaric conditions, but due to decreased HR 
in subject immersed to the neck under hyperbaric conditions. Then an important question 
arises, can continuous hemodynamic measurements under dry conditions, as in study II, 
supplement the changes observed after open water dives? Probably to a certain extent, but in 
order to better understand why open water dives produce more gas bubbles compared to dry 
dives [46] and result in the impaired LV function seen in study I, a more comprehensive PV-
loop animal model under immersed conditions should be implemented.  
 
A       B 
 
 
 
 
 
 
 
 
 
C  
Figure 6: Continuous cardiovascular changes 
during the whole time span of a hyperbaric 
exposure (in minutes).  ● represents rats with 
constant core temperature at 37ºC (W/W). ○ 
represents rats exposed to a 2 ºC core temperature 
drop during decompression and early post dive 
(W/C). A: LV end-systolic pressure (mmHg), B: 
LV end-systolic volume (µL), C: Total peripheral 
resistance (TPR) (mmHg/ml/min). #: Significantly 
different from baseline in the W/W group. +: 
Significantly different from baseline in the W/C 
group. P< 0.05 was set to be statistically 
significant. 
 
 
Our temperature intervention in study II did not increase bubble production and risk of DCS, 
and at most time points during the dive, cardiovascular parameters followed the same pattern 
in both the W/W and W/C group. However, we observed a significant drop in SV and CO in 
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the W/C group during rewarming to 37 ºC (Figure 7 A&B). It was rather surprising that this 
short lasting modest temperature intervention caused hemodynamic changes since reduction 
in CO has previously been reported after cooling and rewarming rats from profound 
hypothermia [169]. This was likely not due to reduced contractile properties since LV ESV 
and preload recruitable stroke work remained at baseline values. Likely there were alterations 
in the peripheral vasculature since there was a tendency of increased TPR (Figure 6C) and one 
can only speculate if the decreased SV was due to vascular escape and pooling in some 
capillaries. Since we only observed the rats for one hour post diving we can not evaluate the 
duration of these changes. This is of specific interest in repetitive SCUBA diving where 
indications of cumulative cardiopulmonary changes have been reported [85]. Since study II 
was performed under dry conditions, and thus lacks the prolonged immersion induced 
cardiovascular changes [42, 94], it is tempting to believe that a rat model including immersion 
and hypothermia would result in increased bubble production and risk of DCS, as seen in 
human trials [104]. Further, the significance of a combination of stressors was also seen in 
study III, where neither solely immersion nor dry hyperbaric dive resulted in impaired cardiac 
function, only a combination of immersion and dry dive did.      
 
A       B 
 
Figure 7: A: Changes in stroke volume (µL) during diving. B: Changes in cardiac output (µL /min) during 
diving. ● represents rats with constant core temperature at 37ºC (W/W). ○ represents rats exposed to a 2 ºC core 
temperature drop during decompression and early post dive (W/C). Red circles highlight significant changes 
during rewarming from 35ºC to 37ºC. #: Significantly different from baseline in the W/W group. +: Significantly 
different from baseline in the W/C group. P< 0.05 was set to be statistically significant.    
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Further perspectives  
In most dive scenarios the human body is able to rapidly adapt to the altered environmental 
challenges imposed by diving. Due to modern SCUBA equipment and by following standard 
decompression procedures, millions of dives are performed worldwide with no reported 
clinical abnormalities. However, based on the cardiopulmonary alterations found on a small 
number of divers in study I, diving induced cardiopulmonary changes are most likely 
significantly underreported. Additionally, the test subjects in study I were all fit, experienced 
search and rescue personnel which is in great contrast to the average recreational dive 
population that no longer include only young and fit people. Although the ascent rate upon 
return to the surface is the main factor controlling DCS risk, it has been shown that young, 
slim aerobic fit divers produced less bubbles than divers with the opposite characteristics 
[170]. The solubility of N2 is higher in pure fats and oils than in water [28] and blood [171], 
thus removal of greater amounts of N2 stored in the lipid tissue of unfit people would require 
extended decompression time. In study I, the trimix divers planned the dive according to the 
Varying Permeability Model (VPM-B), which is a model that calculates dive risk on a 
theoretical and mathematical basis. Models are evolving and have recently begun to 
incorporate individual physiological parameters for more accurate risk analysis [172], but still 
there is a substantial work ahead before we understand the vast individual variation in bubble 
production and risk of DCS in man. Data from human trials give valuable insight to how the 
organism responds diving, but in order to understand why some individuals are more 
“biologically adapted” to diving, there is a need for substantial translational research. Animal 
studies are a powerful tool to investigate mechanisms and etiologies that control the 
physiological responses during a dive, and further investigation of the finding in study II & III 
may result in improved treatment strategies and decompression procedures under various dive 
conditions. Study II & III proved that further research should be addressed cardiovascular 
changes in response to immersion and hypothermia. There is sparse knowledge regarding the 
long tem effect of immersion and its significance has also caught interest in other scenarios, 
such as triathlon, were it is speculated that increased number of swim-related deaths can be 
linked to swimming induced pulmonary edema (SIPE) [152]. Finally, due to the increased 
interest of exploiting the northern areas, improved treatment strategies and decompression 
profiles during cold exposures will be of increasing interest and importance.  
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Main conclusions  
 
I. In healthy individuals performing repetitive trimix diving in three consecutive days, 
asymptomatic acute pulmonary edema (APE) came back to baseline values between 
each dive and resolved within 2-3 hours after each dive exposure. The physiological 
mechanisms of APE are still unclear and should be addressed more attention in the 
medical community since the growing dive population do not only include fit and 
young divers.  
 
II. a) Continuous measurements of cardiovascular function in a dry hyperbaric exposure 
showed that the most conspicuous changes in left ventricular function occurred at high 
atmospheric pressure before gradually decreasing during decompression and returning 
to baseline post diving. This model could not explain the depressed cardiovascular 
changes seen in humans after dives and should be further developed to better mimic 
open water dives. 
     
b) Cold exposure during decompression and early post dive period did not increase 
venous gas bubble production and risk of DCS. The lack of temperature induced 
cardiovascular changes during the dive indicates that tissue perfusion was unaltered 
and hence resulted in unchanged gas uptake and removal at different time points. 
However, rewarming induced a significant drop in SV and CO and further studies are 
needed to elaborate the long term effect of these changes.  
 
III. Immersion before a dry simulated dive resulted in reduced cardiomyocyte function, 
increased bubble production and mortality. The reduced cardiac function was likely 
due to immersion induced hemodynamic changes and support the hypothesis that 
immersion results in prolonged cardiovascular changes that promote bubble 
production and risk of DCS.  
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a b s t r a c t
Recently, an increase in extravascular lung water (EVLW) accumulation with diminished left ventricular
contractility within 60min after SCUBA diving was reported. We have observed previously that diving
was associated with reduced diffusing lung capacity for carbon monoxide (DLCO) and arterial oxygen
pressure for up to 60–80min postdive. Here we investigated whether increased EVLW persists 2–3h
after successive deep dives in a group of seven male divers. The echocardiographic indices of pulmonary
water accumulation (ultrasound lung comets (ULC)) and left ventricular function, respiratory functional
measurements and arterial oxygen saturation (SaO2) were assessed 2–3h post diving, while venous gas
bubbles (VGB) and the blood levels of NT-proBNP and proANP were analyzed 40min after surfacing.
Spirometry values, ﬂow-volume, DLCO, SaO2 and ULC were unchanged after each dive, except for signif-
icant increase in ULC after the second dive. Left ventricular function was reduced, while NT-proBNP and
proANP levels were signiﬁcantly elevated after majority of dives, suggesting a cardiac strain.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
Symptomatic acute pulmonary edema (APE) following self-
contained underwater breathing apparatus (SCUBA) diving, breath
hold diving and endurance swimming is a rather rare complication
(Wilmshurst et al., 1989; Pons et al., 1995; Koehle et al., 2005; Liner
and Andersson, 2008). In a Swiss survey conducted on 1250 SCUBA
divers, only 5 individuals out of 460 responders had a history sug-
gestive of APE (1.1%) (Pons et al., 1995). Having in mind that there
are millions of recreational and professional divers worldwide, the
number of potential individuals that could be at risk of develop-
ing this clinical syndrome is still substantial. Therefore, although of
rare occurrence, the APE syndrome deserves attention of the med-
ical community, especially in countries with strong diving tourism
and industry. A recent analysis of 60 cases of SCUBA-related APE by
Koehle et al. (2005) revealed that affected individuals are typically
healthy (although 5 were hypertensive) but that increasing age
poses an additional risk. The most common clinical manifestations
of APE were cough, dyspnoea and hemoptysis, and in the majority
of cases the symptoms resolved within 5min to 24h after the dive.
Dive depth varied from2.9 to 42mof both salt and freshwaterwith
water temperature ranging from 4.7 to 19 ◦C (Koehle et al., 2005).
∗ Corresponding author. Tel.: +385 21 557 906; fax: +385 21 557 889.
E-mail address: zeljko.dujic@mefst.hr (Z. Dujic).
As with any other clinical disorder, APE after diving may be
asymptomatic and much more frequent than reported due to the
large functional reserve in respiratory gas exchange. In a recent
study performed during a series of successive dives with trimix
(breathing mixtures composed of helium, nitrogen and oxygen),
we observed an enhanced accumulation of extravascular lung
water (EVLW) using technique of ultrasonic lung comet detection
(Agricola et al., 2005; Picano et al., 2006; Marinovic et al., 2009b).
Thiswas paralleled by an augmentedmean pulmonary artery pres-
sure (PAP), diminished left ventricular contractility and increased
release of N-terminal part of the pro-brain natriuretic peptide
(NT-proBNP), suggesting a signiﬁcant cardiopulmonary strain. The
number of ultrasonic lung comets (ULC) and PAP values did not
return to baseline during the course of repetitive dives, indicating
a possible cumulative effect with increasing risk for APE.
The blood–gas barrier between the pulmonary capillaries and
alveoli is very thin allowing for rapid exchange of respiratory gases
during rest and exercise. The permeability of this barrier is usu-
ally expressed as a lung diffusing capacity for carbon monoxide
(DLCO). DLCO is reduced during extravasation of ﬂuid, cells and
proteins from the vascular space that is amajor pathophysiological
event leading to APEs. We have previously reported that simulated
chamber air dives are followed by signiﬁcant arterial hypoxemia
and reduction of DLCO lasting up to 60–80min after dives (Dujic et
al., 1993). This was later conﬁrmed in the ﬁeld dives (Dujic et al.,
2005a).
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Based on our previous ﬁnding of a transient DLCO reduction fol-
lowing the simulated air dives (Dujic et al., 1993), we hypothesized
thatmostof thephysiological signsof asymptomaticAPE (increased
ULC, reduced DLCO and arterial oxygen saturation) will disappear
within 2–3h after diving with trimix in healthy individuals.
2. Methods
2.1. Study population
Seven certiﬁed male SCUBA divers were enrolled in the study.
They were 40.2±9 years old, with average height of 1.8±0.1m
and 84.5±11.1 kgweight. All participantswere experienced divers
of the Croatian Search and Rescue Unit (CSR) and were all non-
smokers. All subjects completed the study and were included in
analysis, and no one developed decompression sickness (DCS) or
associated symptoms. During the study period, the divers showed
no signs of acute or chronic illness and did not use any medication.
All experimental procedures were conducted in accordance with
the Declaration of Helsinki, and were approved by the Ethics Com-
mittee of the University of Split School of Medicine. Each method
and potential risks were explained to the participants in detail and
they gave their written informed consent before the experiment.
2.2. Study design
Divers performed a total of three SCUBA dives in 3 consecutive
days at thedivingdepths ranging from63 to 65mof seawater. They
used a breathingmixture of oxygen (16–17%), helium (44–46%) and
nitrogen (37–39%) (trimix) for a descent and an ascent up to 21m.
During ascent at 21m they switched to a breathing mixture con-
taining oxygen (50%) and nitrogen (nitrox mixture). The bottom
times varied between 13.5 and 16.5min and total dive time includ-
ing decompression varied between 59 and 83min. Water temper-
atures were 19–20 ◦C at the surface and 14–15 ◦C at a bottom.
Diversworedry suits, a SCUBAapparatus andGalileodive computer
(Uwatec, Johnson Outdoors Inc., Racine, WI, USA). Decompression
proﬁles were determined using V-planner software according to
Varying Permeability Model (VPM-B) (Yount and Hoffman, 1986).
Each dive proﬁle was downloaded from the dive computers to a PC
for analysis of the dive’s depth andduration aswell as the heart rate
(HR). Individual dive proﬁles were used to calculate the probability
of DCS (PDCS) as an index of severity of exposure (Gerth and Vann,
1997). The divers restrained from exercise 24h before diving, dur-
ing decompression stop or after dives since these conditions were
reported to reduce venous gas bubbles (VGB) (Dujic et al., 2004,
2005b, 2006a). Subjects did not perform other dives between pre-
dive testing and our postdive measurement and were allowed to
drink water ad libitum immediately after surfacing.
2.3. Timeline of measurements
The pulmonary function assessment and echocardiography
(bubble grade (BG), lung comets and left ventricular function)were
performed 30–40min prior to all dives, and then repeated approx-
imately 120–180min after surfacing (except for the BG that was
measured at 60min postdive). Blood levels of NT-proBNP, pro-
atrial natriureticpeptide (proANP)andalbuminwereassessed from
venous blood samples taken 30–40min before and immediately
after surfacing on days 1 and 3.
2.4. Spirometry, ﬂow-volume and lung diffusing capacity
measurements
Measurements of pulmonary function consisted of spirometry
and single breath lung diffusing capacity (DLCO). For spiromet-
ric tests, three satisfactory maneuvers were collected each time.
The instrument used was the computerized Quark PFT (Cosmed,
Rome, Italy) that was calibrated daily by volume calibration with
a 3 l hand pump and by automatic checking of the proper gas mix-
ture forDLCOmeasurements. Forcedvital capacity (FVC) and forced
expired volume in 1 s (FEV1) were taken as the highest readings
obtained. The maximal expiratory ﬂow rates (MEF) at 75%, 50%,
and 25% of FVC expired and forced mid-expiratory ﬂow rate were
taken from the best test deﬁned by the highest sumof FVC and FEV1
(Anonymous, 1995).
DLCOwas determined in duplicate by the single breathmethod,
which requires the subjects to make maximal inspiration from the
residual volume of a gas mixture containing 21% O2, 0.3% carbon
monoxide and 0.3% methane balanced with nitrogen. Concen-
trations of carbon monoxide were measured using an infrared
analyzer (Quark PFT, Cosmed, Rome, Italy). DLCO was adjusted for
changes in hemoglobin (Hb) and carboxyhemoglobin (HbCO) as
follows:
DLCOcorr = DLCO measured × f (Hb) × f (HbCO),
where f(Hb) = (10.22+Hb)/1.76Hb. This adjusts DLCO to a standard
Hb value of 146g/l as reported by Cotes (1979). In order to correct
for DLCOmeasurements, blood hemoglobinwasmeasured directly
by modiﬁed hemoglobincyanide method on Abbot Cell-Dyn
System 3700 (Abbot Diagnostics Division, Santa Clara, CA, USA).
Alveolar volume (VA) was measured by the single breath methane
dilution and DLCO/VA was calculated. Arterial oxygen saturation
(SaO2) was assessed with pulse oxymeter (504, Criticare Systems,
Waukesha, WI, USA).
2.5. Echocardiographic monitoring and venous gas bubbles
detection
The subjects were placed in supine position and an echocardio-
graphic investigationwith a phase array probe (1.5–3.3MHz) using
Vivid 3 Expert ultrasonic scanner (GE, Milwaukee, USA) was con-
ducted by an experienced cardiologist (AO). VGB were observed as
high intensity echoes in the right heart and the pulmonary artery
(Masurel, 1989). Monitoring was performed at 60min postdive
with divers at rest and after performing two coughs. Images were
graded from 0 to 5 according to the previously reported method
(Eftedal and Brubakk, 1997) and data expressed asmedian (25–75%
quartile range). Detailed information about this technique is pre-
sented elsewhere (Dujic et al., 2004).
2.6. Assessment of extravascular lung water
The presence of extravascular lung water was probed with lung
ultrasound by counting the number of B-lines or ultrasound lung
comets (ULC) (Lichtenstein et al., 1997). The ULC is deﬁned as an
echogenic, coherent, wedge-shaped signal with a narrow origin
arising from the hyperechogenic pleural line and extending to the
far edge of the viewing area. This method of EVLW measurement
was found to correlate well with other methods including chest X-
ray, computerized tomography and thermodilution (Jambrik et al.,
2004; Agricola et al., 2005; Picano et al., 2006). The number of ULC
was assessed from61predetermined chest sites on the anterior and
posterior chest wall (Frassi et al., 2007) and expressed as the sum
of all chest scanning areas. The reproducibility of our approachwas
tested by performing the ULC assessment at two time points in the
same day in absence of a dive.
2.7. Assessment of left ventricular function
Two-dimensional echocardiographic studies were performed
using standardexaminationprotocol aspreviouslydescribed (Obad
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et al., 2007) and the following parameters were derived: end-
diastolic volume (EDV), end-systolic volume (ESV), stroke volume
(SV) and ejection fraction (EF). SV was derived from EDV and
ESV using Teichholz’s formula: SV (ml) = EDV−ESV (Teichholz
et al., 1976). EF was calculated from the following equation:
EF (%) =100× [(EDV−ESV)/EDV], and was used as an index of
cardiac systolic function. Endocardial fractional shortening (FS)
is calculated from the left ventricular inner diameters mea-
sured in systole (LVIDs) and diastole (LVIDd) as follows: FS
(%) =100× (LVIDd− LVIDs)/LVIDd.
2.8. Assessment of circulating NT-proBNP and proANP
The NT-proBNP was measured in blood samples using a com-
mercial kit Elecsys proBNP Immunoassay (Roche Diagnostics
Corporation, Indianapolis, IN, USA), the pro-atrial natriuretic pep-
tide (proANP) concentration was assessed using a commercial
kit for proANP(1-98) enzyme immunoassay (Biomedica Medi-
zinprodukte GmbH & CoKG, Wien, Austria), and the albumin
concentration was measured on Olympus Automatic Analyzer
AU 2700 with Olympus Reagent for Albumin photometric color
test (Olympus Life Science Research Europe GmbH, Munich, Ger-
many). Concentrations of proANP and NT-proBNP were corrected
for increase of albumin after diving to account for the effect of
dehydration following the dives.
2.9. Statistical analysis
Data are given as mean± standard deviation (SD). Normal-
ity of the distribution was conﬁrmed for all parameters using
Kolmogorov–Smirnov test. All the comparisons of parametersmea-
sured for a single dive (pre- and postdive values) were performed
using Student’s t-test for paired samples. Bubble grades were com-
pared using Friedman’s test. In order to examine whether the
parameters changedover the course of consecutive dives (potential
cumulative effects), the ANOVA for repeated measures with Bon-
ferroni post hoc analysis was used. The limit of signiﬁcance was
set at P<0.05. All analyses were done using Statistica 7.0 software
(Statsoft, Inc., Tulsa, OK, USA).
3. Results
3.1. Bubble grade and the heart rate
All divers successfully completed threediveswithout any symp-
toms of DCS or APE. The calculated PDCS ranged from 1.9% to 3.3%.
Venous gas bubbling was found after each dive in all subjects (3
(3–4), 3 (2–3) and 3 (0.5–3) for the ﬁrst, second and the third dive,
Fig. 1. Accumulation of extravascular lung water indicated by ultrasound lung
comets. Shown are the means of ultrasound lung comets (ULC) number before and
after a dive on days 1, 2 and 3. *P<0.05 versus predive value on the same day.
respectively). HR increased from baseline to about 35–40% of max-
imal HR (HRmax, calculated as 220− age) at the bottom phase of
each dive and to about 20% of the HRmax during the decompression
stop at 6m.
3.2. Pulmonary functional measurements
Table 1 shows spirometry, ﬂow-volume, DLCO and SaO2 data
for 7 divers collected 30–40min predive and 120–180min post-
dive for dives 1–3. No statistically signiﬁcant differences between
pre- and postdive were found in spirometry (FVC, FEV1, FVC/FEV1,
FEF25–75%), ﬂow-volume curves (MEF75%, MEF50%, MEF25%), DLCO
(DLCOcorr, DLCOcorr/VA) and SaO2.
3.3. Ultrasonic lung comets
As displayed in Fig. 1, the sum of ULC signiﬁcantly increased
after the second dive from 7.7±4.5 to 12.7±3. 9 (P=0.015), with
similar non-signiﬁcant trends for the ﬁrst 6.1±2.5 versus 8.1±2.5
(P=0.18) and the third dive 9.4±4.5 versus 13.1±4.7 (P=0.11)
(predive and postdive values, respectively).Moreover, the ULC pre-
dive value was higher in dive 3 compared to that detected in dive
1, but the statistical signiﬁcance was not reached (P=0.12).
3.4. Left heart function
Assessment of the left ventricular function revealed a decreased
FS and EF with increased ESV and EDV after each dive (Table 2). No
Table 1
Parameters of pulmonary function.
Dive 1 Dive 2 Dive 3
Predive Postdive Predive Postdive Predive Postdive
FVC (% predicted) 119.0 ± 18.1 117.3 ± 13.4 117.8 ± 14.3 116.9 ± 15.3 117.7 ± 14.1 119.0 ± 11.6
FEV1 (% predicted) 109.2 ± 11.3 107.5 ± 9.7 107.6 ± 10.3 109.4 ± 8.1 106.5 ± 9.5 108.3 ± 6.9
FVC/FEV1 (%) 95.3 ± 9.8 96.6 ± 8.7 95.1 ± 8.8 97.0 ± 9.2 94.5 ± 8.5 94.6 ± 8.5
FEF25–75% (% predicted) 83.4 ± 17.0 83.7 ± 15.1 81.0 ± 14.4 85.4 ± 14.5 79.5 ± 14.0 19.8 ± 13.8
MEF75% (% predicted) 90.0 ± 15.0 92.9 ± 13.3 89.8 ± 14.2 92.6 ± 12.6 88.7 ± 14.2 88.5 ± 12.0
MEF50% (% predicted) 86.3 ± 21.9 84.2 ± 17.5 81.5 ± 15.3 85.5 ± 17.0 78.4 ± 12.7 78.2 ± 14.7
MEF25% (% predicted) 74.1 ± 17.2 76.2 ± 15.8 74.1 ± 17.2 80.8 ± 20.3 72.6 ± 17.1 77.1 ± 17.9
DLCOcorr (ml/min/mmHg) 34.4 ± 3.8 34.4 ± 4.4 34.2 ± 4.6 32.4 ± 4.1 31.5 ± 3.7 32.5 ± 3.5
DLCOcorr/VA (ml/min/mmHg/l) 4.4 ± 0.5 4.5 ± 0.5 4.3 ± 0.5 4.4 ± 0.5 4.3 ± 0.5 4.4 ± 0.5
SaO2 (%) 97.8 ± 0.8 97.7 ± 0.7 98.1 ± 0.4 98.4 ± 0.7 98.1 ± 0.9 97.6 ± 0.7
Spirometry, ﬂow-volume, carbonmonoxide diffusing capacity and arterial oxygen saturationwere assessed before and120–180min after each dive. FVC, forced vital capacity;
FEV1, forced expiratory volume in1 s; FEF25–75%, forcedmid-expiratoryﬂow;MEF,maximal expiratoryﬂowratesmeasured at 75%, 50%, and25%of FVC;DLCOcorr, lungdiffusing
capacity for carbon monoxide corrected for changes in hemoglobin and carboxyhemoglobin; VA, alveolar volume; SaO2, arterial oxygen saturation.
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Table 2
Parameters of left ventricular function.
Dive 1 Dive 2 Dive 3
Predive Postdive Predive Postdive Predive Postdive
FS (%) 35.29 ± 1.8 34.0 ± 1.5† 36.0 ± 0.6 33.6 ± 1.3* 36.0 ± 1.2 33.1 ± 1.1*
EF (%) 64.1 ± 2.6 62.4 ± 2.0 65.2 ± 1.0 62.3 ± 1.4* 65.4 ± 1.5 61.7 ± 1.2*
SV (ml) 73.7 ± 10.6 76.9 ± 12.0 76.5 ± 12.3 74.7 ± 12.4 74.9 ± 12.8 75.9 ± 12.6
EDV (ml) 114.4 ± 16.7 123.1 ± 20.3* 117.3 ± 18.9 106.3 ± 27.6 114.4 ± 19.4 123.2 ± 19.7*
ESV (ml) 40.9 ± 6.9 46.3 ± 8.6* 41.0 ± 6.8 45.0 ± 6.7* 39.6 ± 6.9 47.2 ± 7.1*
HR (bpm) 61.1 ± 6.9 66.6 ± 6.7 64.0 ± 4.2 66.1 ± 8.2 64.0 ± 5.0 67.6 ± 9.2
CO (l/min) 4.5 ± 0.7 5.1 ± 0.6* 4.9 ± 0.6 5.0 ± 1.0 4.8 ± 1.0 5.1 ± 0.7
The performance of the left heart was evaluated ultrasonographically before diving and 120–180min after surfacing. FS, endocardial fractional shortening; EF, ejection
fraction; SV, stroke volume; EDV, end-diastolic volume; ESV, end-systolic volume; HR, heart rate; CO, cardiac output.
* P<0.05 versus baseline value obtained on a same day.
† P=0.078 versus Predive on the same day.
Table 3
Concentration of vasoactive hormones.
Dive 1 Dive 3
Predive Postdive Predive Postdive
NT-proBNP (pmol/l) 6.4 ± 0.3 7.4 ± 1.8 6.0 ± 0.9 6.9 ± 1.0*
ProANP (nmol/l) 0.6 ± 0.3 2.4 ± 1.2* 0.4 ± 0.3 2.3 ± 0.5*
Albumin (g/l) 46.7 ± 1.2 48.7 ± 1.9* 43.9 ± 2.3 46.6 ± 2.6*
The levels of N-terminal part of the pro-brain natriuretic peptide (NT-proBNP), pro-
atrial natriuretic peptide (proANP) and albumin were measured in blood samples
taken ∼40min before and after dives 1 and 3.
* P<0.05 versus baseline on a same day.
changes in SV, HR and cardiac output were found. No differences in
predive values between any of the days were found.
3.5. Vasoactive hormones
When compared to baseline values, NT-proBNP levels were sig-
niﬁcantly increased after dive 3 with similar trend after dive 1
(Table 3). Plasma ProANPwas signiﬁcantly elevated after both dive
1 and 3. Both dives resulted in a signiﬁcant hemoconcentration, as
evidenced by the increased postdive blood albumin levels. No dif-
ferences in predive albumin concentration between dives 1 and 3
were found.
4. Discussion
4.1. Accumulation of EVLW and cardiac function
In our previous study with repetitive deep trimix dives we
observed a threefold increase in ULC number at 40min after each
assessed dive (Marinovic et al., 2009b). A similar trend of ULC
increase was also reported after apnea dives (Frassi et al., 2008),
in patients undergoing hemodialysis (Noble et al., 2009), as well as
in the heart failure patients (Frassi et al., 2007). In the current study
we examined whether the ULC increase persists 2–3h after a dive.
We found that most of the ULC increase was not present at that
time, although a slight increase by 20–30% still persisted. Since this
effect was detected in all individuals after every dive, these data
suggested that most of the pulmonary changes including EVLW
accumulation lasted only for a short time after a dive. However,
while the respiratory function completely returned to its predive
levels, the cardiac function remained altered. Due to technical rea-
sons, we were unable to measure all physiological parameters at
each and every time point after diving and hence we cannot claim
with complete certainty that increased ULC were indeed present
immediately afterdiving.However, sincewemeasuredBG,proANP,
NT-proBNP and albumin concentration 40min after dives and all
variables changed as expected (an increase in all parameters), we
believe that the formation of interstitial lung edema immediately
after diving likely occurred as previously reported (Marinovic et al.,
2009b) and that at the 2–3h after the dives the excess EVLW was
already largely resolved.
The physiological mechanism(s) leading to the symptomatic
and asymptomatic APE in SCUBA diving is (are) unknown, but can
involve several factors: (a) immersion-induced blood centraliza-
tion due to enhancement of venous return and increased cardiac
preload (Marabotti et al., 2009). The consequential increase in pul-
monary blood volume and transmural capillary pressure may lead
to capillary stress failure, extravasation of plasma and alveolar ﬂuid
ﬂooding (Sartori et al., 2007); (b) cold-induced peripheral vaso-
constriction, resulting in increased cardiac afterload; (c) increased
intrathoracic negative pressure due to increased breathing resis-
tance during SCUBA diving (Ronnestad et al., 1994), causing a
further increase in venous return; (d) an increased vascular per-
meability elicited by the enhanced ANP secretion due to right atrial
stretch (caused by diving-induced blood centralization) (Brenner
et al., 1990); (e) moderate exercise during the dive, since high level
endurance exercise has previously been reported to rarely induce
transient APE (McKenzie et al., 2005); (f) exposure to elevated
oxygen level during a dive, which is associated to an endothe-
lial damage in the pulmonary capillaries and alveoli, resulting
in interstitial and alveolar edema (Crapo, 1986; Clark and Thom,
2003); and (g) VGB, since diving is regularly associatedwith various
extent of venous gas bubbling that can contribute to development
of APE by causing pulmonary microembolisations and damage to
the pulmonary vascular endothelium in animal and human model
(Hlastala et al., 1979; Butler et al., 1996; Nossum et al., 2002;
Brubakk et al., 2005). Previously, we have shown that even a sin-
gle air chamber dive caused a signiﬁcant bubble production and
a reduction in DLCO and arterial oxygen partial pressure (Dujic et
al., 1993). Thus, there is evidence that VGB could be a contributing
factor to the EVLWaccumulation. However, in the current study, as
well as in our previous study (Marinovic et al., 2009b) with mod-
erate bubble loads, we found no correlation between the bubble
grades and ULC, suggesting that development of APE is complex
and still poorly understood clinical problem.
In addition to the above-mentioned factors that could possi-
bly contribute to EVLW accumulation during and after a dive, we
also observed changes in cardiac function that may play a part
in the EVLW buildup. A postdive decrease in the left ventricu-
lar EF and FS with increased ESV and EDV are indicative of a
reduced left ventricular contractility that could further promote
an increase in the pulmonary blood volume and resulting capil-
lary stress. These ﬁndings are similar to those from our previous
studies (Dujic et al., 2006b; Obad et al., 2007; Marinovic et al.,
2009a). An absence of changes in stroke volume, heart rate and,
consequently, cardiac output that were previously reported after
air SCUBAdiving (Boussuges et al., 2006; Dujic et al., 2006b)may be
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ascribed to a successful rehydration by the timeof the ECHOassess-
ment (120–180min) or an increase in cardiac contraction elicited
by greater ventricular ﬁlling (as evidenced by elevated EDV) which
may offset a reduction in contractility (indicated by a diminished
EF).
4.2. Concentration of NT-proBNP and proANP
In addition to echocardiographic changes detected after diving,
hormonal indices of atrial (proANP) and ventricular (NT-proBNP)
wall stress were also increased. This conﬁrms previous ﬁnding of
a postdive increase in the plasma levels of NT-proBNP that was
recently reported by our group (Marinovic et al., 2009b) and oth-
ers (Gempp et al., 2005). Furthermore, elevated levels of plasma
proANP levels were previously found during water immersion
(Epstein et al., 1987) and saturation dives (Tao et al., 1992). These
hormonal changes were most likely caused by the increased car-
diac preload and afterload during and after diving. Cardiac release
of natriuretic peptides could also potentiate the accumulation of
the EVLW since ANP augments the endothelial permeability and
leads to increased extravascular ﬂuid and albumin accumulation in
the pulmonary circulation (Curry, 2005).
4.3. Spirometry and lung diffusing capacity
The ﬁnding of unchanged spirometric and ﬂow-volume param-
eters 2–3h after each trimix dive is in accordance to our previous
study in which 8 recreational divers performed a single air dive
to 39m for 30min and spirometric testing was done 90min after a
dive (Dujic et al., 2005a). However, the ﬁnal conclusion is still unre-
solved since others have found FVC reduction after ocean dives to
10m (53min) or to 50m (38min) (Skogstad et al., 1996). Tetzlaff et
al. (2001) reported a FVC reduction only after a cold dive exposure
to 50m, but not following dive at 50m at ambient water tem-
perature nor cold water exposure at 10m. In a study with larger
number of recreational divers comparingwet versus dry hyperbaric
chamber exposures to 0.6MPa (51m water) for 15min, no signif-
icant changes were observed in spirometric values or DLCO at 3
and 24h postdive (Tetzlaff et al., 1999). Thus, wet exposure and
immersion alonemay not be responsible for changes in pulmonary
function, but bronchoconstriction due to cold was suggested to be
the likely causal factor. With relatively moderate summer water
temperatures at Croatian coast, a cold water effect is unlikely in
this study.
In the present study, no change in postdive (120–180min)DLCO
valueswas found. Previous studies have reported diminishedDLCO
following both dry andwet dives inwhich venous gas bubbleswere
detected (Dujic et al., 1993, 2005a; Thorsen et al., 1995). Follow-
ing a dry dive to 45m for 25min, DLCO was reduced signiﬁcantly
in proportion to maximal bubble grade (Dujic et al., 1993), and
a similar ﬁnding was subsequently shown for wet dive to 39m
(30min) (Dujic et al., 2005a). Since this effect persisted only for
60–80min after dry or wet dive, the current ﬁnding of unchanged
DLCOat 120–180minafter emersion is in accordancewithprevious
reports (Dujic et al., 2005a). Furthermore, a recent study showed
unchanged DLCO and V/Q ratio at least 1h after a dry chamber dive
(Moore et al., 2009).
4.4. Study limitations
The ﬁndings of the present study have to be viewed with cau-
tion due to a small number of subjects. However, the strength of
this work was improved by the repeated intra-individual mea-
surements (predive and postdive) thus facilitating detection of any
potential changes in the measured physiological parameters. Fur-
thermore, as described above, future research on cardiovascular
effects of repetitive SCUBA dives should be done with recreational
divers and not with experienced divers. One limitation of the cur-
rent study was that ULC were measured only at one time point,
120–180min following a dive. Although ideally we would have
measured ULC at additional timepoints (i.e. within 60min after a
dive), this was not possible due to the technical reasons (measure-
ment of other parameters at that time point such as VGB and taking
theblood samples). Adetailedassessmentof time-resolutionofULC
is planned in the future.
5. Conclusion
In accordance to our hypothesis, the presence of interstitial
lung edema after recreational SCUBA diving with trimix mixture
lasts very shortlywith renormalizationof respiratory gas exchange,
transfer of water between vascular and interstitial spaces, and
arterial saturation within 2–3h after diving. This study suggests
that, besides the signiﬁcant impact on cardiac function, deep dives
of modest severity do not cause major pulmonary gas exchange
alterations. However, one should bear in mind that these phe-
nomena were studied in relatively limited number of experienced
Search and Rescue divers that are frequently exposed to vari-
ety of environmental stressors such as high and low pressure,
hypoxia and hyperoxia, cold and warm temperatures, extreme
exercise or breathing of dense air mixture. It is therefore pos-
sible that they are non-speciﬁcally preconditioned to any stress
such as a combination of diving and moderate exercise and conse-
quently do not represent the average diving population. Therefore,
future work on this topic should be done on a larger number
of recreational healthy divers and individuals with common car-
diovascular abnormalities (such as arterial hypertension) in order
to analyze the risk for developing asymptomatic or symptomatic
APE.
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